Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy
Xiaotong Wang,1,* Haixiong Lin,2,* Shuai Xu,3 Yuanlin Jin,1 Ren Zhang4 1Shenzhen Bao’an Traditional Chinese Medicine Hospital Group, Guangzhou University of Chinese Medicine, Shenzhen 518133, People’s Republic of China; 2The First School of Clinical Medicine, Guangzhou University...
Saved in:
Main Authors: | Wang XT (Author), Lin HX (Author), Xu S (Author), Jin YL (Author), Zhang R (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diabetes and alpha lipoic acid
by: Issy eLaher
Published: (2011) -
The Health Effects of Alpha Lipoic Acid
by: Armağan Yürük, et al.
Published: (2014) -
Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG
by: Sangeetha Iyer, et al.
Published: (2019) -
Therapeutic Potential of Alpha-Lipoic Acid in Viral Infections, including COVID-19
by: Stela Dragomanova, et al.
Published: (2021) -
Therapeutic use of alpha lipoic acid in burning mouth syndrome: A meta-analysis
by: Shubhabrata Roy, et al.
Published: (2021)